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Abstract
Background: The hNaa10p (hArd1) protein is the catalytic subunit of the human NatA Nα-
terminal acetyltransferase complex. The NatA complex is associated with ribosomes and
cotranslationally acetylates human proteins with Ser-, Ala-, Thr-, Val-, and Gly- N-termini after the
initial Met- has been removed. In the flexible C-terminal tail of hNaa10p, there are several potential
phosphorylation sites that might serve as points of regulation.
Findings: Using 2D-gel electrophoresis and hNaa10p specific antibodies, we have investigated
whether hNaa10p is phosphorylated in HEK293 cells. Several differently charged forms of hNaa10p
are present in HEK293 cells and treatment with Calf Intestine Alkaline Phophatase (CIAP) strongly
suggests that hNaa10p is phosphorylated at multiple sites under various cell culture conditions. A
direct or indirect role of GSK-3 kinase in regulating hNaa10p phosphorylation is supported by the
observed effects of Wortmannin and LiCl, a GSK-3 activator and inhibitor, respectively.
Conclusion: We demonstrate that hNaa10p protein is phosphorylated in cell culture potentially
pointing at phosphorylation as a means of regulating the function of one of the major Nα-terminal
acetyltransferases in human cells.
Background
Protein Nα-terminal acetylation is a very common protein
modifications in eukaryotic cells, and approximately 80%
of soluble human proteins is estimated to carry this mod-
ification. In humans, the hNatA complex is the major Nα-
terminal acetyltransferase, acetylating Ser-, Thr-, Val-, Ala-
, Gly- N-termini after the initial Met- has been removed by
Methionine aminopeptidases [[1], Arnesen T and Van
Damme P et al., submitted]. The recently described
human NatB and NatC complexes are composed of dis-
tinct subunits and acetylate different subsets of Met-ter-
mini [[3,3], Starheim et al., submitted]. The hNatA
complex composed of the catalytic subunit hNaa10p
(hArd1) and the auxiliary subunit hNaa15p (hNat1) [4,5]
is functionally conserved from yeast displaying almost
identical substrate specificity (Arnesen T and Van Damme
P  et al., submitted). Naa10p, Naa11p, Naa15p and
Naa16p represent the novel names of Ard1, Ard2, Nat1
and Nat2, respectively, and will be officially presented
later this year when the nomenclature of this enzyme class
is revised (Polevoda B, Arnesen T and Sherman F, unpub-
lished). hNaa10p and/or hNaa15p has been demon-
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strated to be important for cell survival [6-8] suggesting
important functions for hNaa10p or hNatA mediated
acetylation in human cells. In humans, there are two par-
alogues for each NatA subunit, hNaa10p and hNaa11p
[9], and hNaa15p and hNaa16p (Arnesen et al., submit-
ted), potentially creating a more flexible and complex sys-
tem for NatA mediated N-terminal acetylation as
compared to lower eukaryotes.
The C-terminus of hNaa10p is flexible [10] and contains
many Ser- and Thr- amino acid residues that potentially
might serve as a phosphorylation sites that depending on
the phosphorylation state may modify the function of the
protein. To investigate the possible phosphorylation of
hNaa10p and the kinase involved, we analyzed hNaa10p
by 2D-gel electrophoresis and Western blotting using anti-
hNaa10p. Indeed, the 2-D electrophoresis pattern of
hNaa10p indicated multiple isoforms with different
charges which is consistent with the hNaa10p protein
being phosphorylated at multiple residues. Furthermore,
GSK-3 kinase, a highly conserved regulatory serine/threo-
nine protein kinase, is involved in these phosphorylation
events.
Methods
Unless otherwise stated, HEK293 Cells were grown in
Dulbecco's modified Eagle's medium (DMEM) supple-
mented with 10% heat-inactivated foetal bovine serum
(FBS) and 2% L-Glutamine in 60 mm dishes (Nunc) at
37°C and 5% CO2.
After cell harvesting, the proteins were precipitated by
addition of 1 ml cold (4°C) 7% TCA, centrifuged at 13000
g for 5 minutes, and the supernatant was poured off. The
proteins were resuspended and rinsed in 1 ml cold (4°C)
5% TCA, centrifuged at 13000 rpm for 5 minutes, and the
supernatant was poured off again. The protein pellet was
rinsed three times in H2O-saturated ether (to remove
TCA) and centrifuged at 13000 rpm for 5 minutes after
each washing step. The pellets were dried at room temper-
ature until they detached from the tube walls and were
free of ether, for approximately one hour. Each pellet was
dissolved in 100 μl rehydration buffer (6 M urea, 2 M
thiourea, 4% (w/v) CHAPS, 20 mM DTT, 0.5% (v/v) Tri-
ton X-100, trace amounts of bromophenol blue) and son-
icated for 5 × 10 seconds to improve solubilisation. The
protein samples were stored at -80°C until analysis by 2D-
PAGE. Typically 50 μl of protein sample (from approxi-
mately 5 × 106 cells) was mixed with 300 μl and 200 μl
rehydration buffer for 18 and 13 cm IPG strips respec-
tively, and then 1.75 μl ampholytes (0.5%) were added.
pH range of the ampholytes varied according to the IPG
strips pH-range. The solution was centrifuged at 13000
rpm (Heraeus Biofuge 13), for 10 minutes to separate and
remove any insoluble aggregates. The whole volume of
the rehydration solution was applied on an Immobiline
DryStrip Reswelling Tray (Pharmacia Biotech) with an
Immobilized pH Gradient gel DryStrip (IPG strip) (Phar-
macia). After rehydration at room temperature for 12–15
hours, isoelectric focusing (IEF) was performed with
either Multiphor II™ Flat Bed Electrophoresis Unit (Phar-
macia), connected to an EPS 3501 XL Power Supply
(Pharmacia), or the Ettan IPGphor™ Isoelectric Focusing
Unit (Amersham Biosciences). After isoelectric focusing
the IPG strips were put in a Petri dish for direct equilibra-
tion by SDS equilibration buffer with 100 mM DTT and
thereafter SDS equilibration buffer containing 55 mM
iodoacetamide, before analysis by second dimension
SDS-PAGE (12.5% polyacrylamide) using the PROTESN
II xi 2-D system (20 cm) from Bio-Rad.
SYPRO Ruby protein gel stain (BioRad) was used (accord-
ing to instruction manual) to visualize proteins in general.
To detect the hNaa10p protein, we performed Western
blotting of 2D-PAGE gels utilizing the Multiphore II
NovaBlot Electrophoretic Transfer Unit. After protein
blotting, the nitrocellulose membrane was incubated in
5% dry milk diluted in PBS-Tween overnight at 4°C. The
membrane was incubated with anti-hNaa10p antibody
[4], diluted (1:500) in 1% dry milk, for 1 hour in room
temperature. After washing, 3 × 10 minutes with PBS-
Tween, the membrane was incubated for 1 hour with anti-
rabbit conjugated to HRP (Amersham Biotech) diluted
1:2000 in PBS-Tween. After washing 3 × 10 minutes with
PBS-Tween and once with PBS, ECL technology was used
to develop the protein blot (Amersham Pharmacia).
Results and discussion
In order to investigate potential post-translational modifi-
cations of hNaa10p, the protein sequence was analyzed
by ELM (ELM) algorithm, publically available at http://
elm.eu.org/ that predict functional sites in eukaryotic pro-
teins. The algorithm predicted 13 potential phosphoryla-
tion sites [11] in hNaa10p sequence recognized by
different kinases such as Casein Kinase I (CKI), Casein
Kinase II (CKII), and Glycogen Synthase Kinase-3 (GSK-3)
(Table 1). In particular, the C-terminal region of hNaa10p
had as many as 10 out of the 13 predicted phosphoryla-
tion sites. Of note is that the C-terminus (aa 180–235) of
hNaa10p has been demonstrated to be unstructured and
flexible [10]. Thus, these residues are likely to be accessi-
ble for kinases.
The presence of endogenous hNaa10p protein has been
demonstrated in several human cell lines, using a specific
antibody [4]. 1D-SDS-PAGE and immunoblotting with
specific antibody demonstrated the endogenous hNaa10p
protein to be approximately 30 kDa as expected from the
predicted open reading frame resulting in a protein of 235
amino acid residues.BMC Research Notes 2009, 2:32 http://www.biomedcentral.com/1756-0500/2/32
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Due to the ability of 2D-PAGE to separate and visualize a
very large number of proteins in complex mixtures of
polypeptides according to their pI value and molecular
weight, it is suitable for the investigation of posttransla-
tional modifications (PTMs) which result in changes in
molecular mass and pI, such as phosphorylation.
Therefore, this method was applied to study endogenous
hNaa10p forms expressed in HEK293 cell cultures. Pro-
tein extracts of HEK293 cells were separated by 2D-PAGE
and proteins visualized by SYPRO Ruby, clearly demon-
strating a nice resolution (Figure 1A). The hNaa10p pro-
tein was detected in the 2D-PAGE by protein immunoblot
(Figure 1B), and its position corresponded to approxi-
mately 30 kDa and a pI value of approximately 5.0. The
protein was further analyzed by narrowing the immobi-
lized pH gradient used for IEF (Figure 1C). The increased
resolution of the first dimension revealed hNaa10p-spe-
cific polypeptides with different pIs. The "train" of spots
observed for the hNaa10p protein could represent multi-
ple isoforms which is typical for multiple posttransla-
tional modifications [12].
The ELM search suggested that hNaa10p might be phos-
phorylated at 7 residues by GSK-3 (Table 1). We therefore
investigated whether inhibition or activation of GSK-3
would result in changes in hNaa10p 2D-PAGE mobility
consistent with a change in its phosphorylation state.
GSK-3 is a highly conserved and widely expressed serine/
threonine protein kinase that plays a central role in the
regulation of several physiological processes [13]. Inhibi-
tion of phosphatidyl inositol 3 kinases (PI3Ks) by Wort-
mannin inactivates Akt kinase, which results in the
indirect activation of GSK-3 kinase [14]. Thus, addition of
Wortmannin should alter the hNaa10p 2D-PAGE mobil-
ity pattern if hNaa10p is a GSK-3 substrate. There was an
acidic shift of the hNaa10p protein isoforms as a conse-
quence of Wortmannin treatment in vivo as compared to
control cells (Figure 2A–B), suggesting that hNaa10p is
more extensively phosphorylated in the Wortmannin
treated cells than in the non-treated cells. The mobility
shift corresponded to the addition of 4–6 phosphate
groups, estimated using bioinformatic tools http://
au.expasy.org/tools/pi_tool.html. To further investigate
the acidic shift caused by Wortmannin treatment, the
experiment was combined with in vitro treatment with
Calf Intestine Alkaline Phosphatase (CIAP). HEK293 cells
were treated with Wortmannin; the protein content of the
cells was divided into two aliquots, one aliquot was added
CIAP, while the other remained untreated serving as con-
trol. The results indicate that in vivo stimulation of the
cells by Wortmannin induces an acidic shift of the protein
as expected (Figure 2C), while in vitro treatment with CIAP
caused reversal of the acidic shift (Figure 2D). This indi-
cates that the acidic shift was mainly caused by phospho-
rylation induced by GSK-3 activation, suggesting that
Table 1: Potential hNaa10p phosphorylation sites predicted by ELM.
Amino acid position#
(P-site in bold)
Peptide Sequence
(P-site in bold)
Predicted Kinase Phospho-site pattern*
186–189 SPPS CKI SXX([ST])
213–216 SEVS
216–219 SETT
228–231 SEAS
131-134 SEVE CKII ([ST])XXE
189-192 SSGE
180–186 (182)V E SKGNS GSK-3 ([ST])XXX [ST]
184–190 (186)G N SPPSS
203–209 (205)E D SGGDS
207–213 (209)G D SKDLS
216–222 (218)S E TTEST
225–231 (227)K D SSEAS
229–235 (231)E A SDSAS
149–155 (152) RDLTQMA PIKK XXX([ST])Q
111–117 (114) VRKSNRA PKA XRX([ST])
183–189 (186)K G N SPPS Proline-Directed kinase (e.g. MAPK) XXX([ST])P
#Prediction of phosphorylation sites were performed using bioinformatic algorithm ELM, publically available at http://elm.eu.org/. *CKI, CKII and 
GSK-3 may use acidic or a primed (pre-phosphorylated) residue at the indicated position relative to the phosphorylation site.BMC Research Notes 2009, 2:32 http://www.biomedcentral.com/1756-0500/2/32
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GSK-3 kinase is involved in the phosphorylation of
hNaa10p.
Further and to confirm GSK-3 involvement in hNaa10p
phosphorylation, we applied in vivo treatment of cells
with LiCl, an inhibitor of GSK-3 and one of the most effec-
tive drugs for the treatment of bipolar (manic-depressive)
disorder [13]. To further explore the possibility that
hNaa10p protein is phosphorylated by GSK-3 kinase,
control cells (Figure 3A) were compared to cells treated
with Wortmannin (Figure 3B) or Wortmannin and LiCl in
combination (Figure 3C). The Wortmannin treatment
results (Figure 3B) confirmed the results presented in Fig-
ure 2, that Wortmannin indirectly activates GSK-3 and
induces acidic shifts of several hNaa10p isoforms. In this
experiment, however, we only observed a Wortmannin-
induced mobility shift corresponding to 1–2 phosphor-
ylation sites. Addition of the GSK-3 inhibitor LiCl to cell
cultures receiving Wortmannin counteracted the Wort-
mannin-mediated phosphorylation of hNaa10p (Figure
3C). This result strengthens further that GSK-3 phosphor-
ylates hNaa10p in HEK293 cells.
We then investigated the phosphorylation status of
hNaa10p under different cell culture conditions. To deter-
mine the hNaa10p protein state in apoptotic cells, cells
were grown to confluence and kept for approximately 15
days without medium change when clear signs of apopto-
sis could be observed by light microscopy (data not
shown). 2D-PAGE-Western blots demonstrated that
hNaa10p undergoes cleavage in apoptotic cells (Figure
4B) as reported previously [4]. The cleaved hNaa10p frag-
ment detected by the anti-hNaa10p antibody is more
basic than the full-length protein, indicating a cleavage
site in the C-terminal region since the amino acid residues
in this region are more acidic as compared to residues of
the N-terminal region. Interestingly, in the apoptotic cells,
hNaa10p is not extensively phosphorylated.
Then, cells were stimulated in vivo with arsenic oxide
(As2O3), which acts on cells through a variety of mecha-
nisms, influencing numerous signal transduction path-
ways and resulting in a vast range of cellular effects that
include apoptosis induction, growth inhibition, promo-
tion or inhibition of differentiation, and angiogenesis
inhibition [15]. Interestingly, cell stimulation with 0.3
mM arsenic induced an acidic shift of the hNaa10p pro-
tein (Figure 4D) while 0.1 mM arsenic did not have any
significant effect on hNaa10p (Figure 4C). It should be
noted that all arsenic treated cells in these experiments did
not show any signs of apoptosis.
hNaa10p was then investigated in HEK293 cells grown to
confluence without medium change (for 6 days), these
cell cultures are in a steady state with respect to cell
Detection of the hNaa10p protein by 2D-SDS PAGE Figure 1
Detection of the hNaa10p protein by 2D-SDS PAGE. 
80 μg of purified proteins from HEK293 cells were applied to 
both (A) and (B), and 50 μg proteins to (C). Molecular-size 
markers are indicated to the left. (A) A 18 cm NL IPG 3–10 
was used in the first dimension, followed by SDS-PAGE in the 
second dimension. Proteins were visualized by using SYPRO-
Ruby staining. (B) A 18 cm NL IPG 3–10 was used in the first 
dimension, followed by SDS-PAGE in the second dimension. 
Proteins were transferred to a nitrocellulose membrane and 
immunostained using anti-hNaa10p. (C) A 13 cm IPG 4–7 
was used in the first dimension followed by SDS PAGE in the 
second dimension. Proteins were transferred to a nitrocellu-
lose membrane and immunostained using anti-hNaa10p.
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number per dish and most cells are presumably in the G0-
phase (Figure 5A). These cultures showed no signs of
apoptosis as observed by light microscopy. For compari-
son the hNaa10p status was also analysed in extracts from
rapidly dividing HEK293 cells subcultivated with fresh
medium 16 hours before harvest (Figure 5B). The results
indicate that hNaa10p is more phosphorylated in resting
cells than in actively dividing cells.
Activation of GSK-3 kinase leads to a phosphorylation  induced acidic shift of hNaa10p Figure 2
Activation of GSK-3 kinase leads to a phosphoryla-
tion induced acidic shift of hNaa10p. Cells were in vivo 
stimulated with Wortmannin 1 μM for 8 hours, cells which 
remained untreated served as control. Furthermore, Wort-
mannin treated cells were divided in to two aliquots, one was 
treated with 20 U/ml CIAP enzyme, while the other 
remained untreated and served as negative control for this 
experiment. 50 μg of resuspended proteins were analyzed by 
2D-SDS PAGE using 13 cm IPG pH 4–7 for IEF, and hNaa10p 
was detected by immunoblotting using anti-hNaa10p. Molec-
ular size markers are indicated to the left. (A) control, 
unstimulated cells, and (B) cells were stimulated with 1 μM/8 
hours Wortmannin. (C) Cells were stimulated with 1 μM/8 
hours Wortmannin in vivo (control for D), and (D) cells were 
stimulated with 1 μM/8 hours Wortmannin in vivo, and the 
purified proteins from these cells were treated with CIAP in 
vitro.
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The phosphorylation of hNaa10p caused by activation of  GSK-3 kinase is reversed by a GSK-3 inhibitor Figure 3
The phosphorylation of hNaa10p caused by activa-
tion of GSK-3 kinase is reversed by a GSK-3 inhibitor. 
Cells were stimulated in vivo with Wortmannin or both LiCl 
+ Wortmannin. Cells stimulated with neither LiCl nor Wort-
mannin served as negative control. 50 μg of the resuspended 
proteins in rehydration buffer were analyzed by 2D-SDS 
PAGE using 13 cm IPG pH 4–7 for IEF, and hNaa10p was 
detected by immunoblotting using anti-hNaa10p. The molec-
ular size markers are indicated to the left. (A) negative con-
trol, cells were unstimulated, (B) cells were stimulated by 
Wortmannin in vivo (1 μM/8 hours), and (C) cells were stim-
ulated with both Wortmannin (1 μM/8 hours) and LiCl (50 
mM) in vivo.
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In conclusion, our results suggest that hNaa10p is phos-
phorylated in vivo and that GSK-3 kinase is phosphorylat-
ing and possibly regulating the hNaa10p protein. Since
GSK-3 may phosphorylate Ser/Thr-residues if the n+4
position is primed/pre-phosphorylated (Table 1) [16],
there are most likely one or more additional kinases
responsible for hNaa10p phosphorylation. Further stud-
ies are needed to determine whether and which additional
kinases are involved in hNaa10p phosphorylation, to
reveal the modification sites within hNaa10p and the
functional consequences of such phosphorylations.
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